Citrine Medicine Co., Ltd – co-founded by Eight Roads, F-Prime Capital and Vivo Capital – on Monday announced the completion of its $80-million Series A round led by next-generation life science-focused Quan Capital, per a company statement.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
